Receptor tyrosine kinases (RTKs) are pivotal in both normal cellular functions and cancer progression, activating critical signaling pathways. In cancer therapy, targeted therapies using monoclonal ...

Figure 1: Graphical illustration of the main findings from Pfeiffer et al., Cancer Research, 2022. The SH2 domain-containing tyrosine phosphatase 2 (SHP2) is a ubiquitously expressed non-receptor ...

The deregulation of receptor tyrosine kinases (RTKs) has been implicated in nearly all forms of human cancer. As such, RTKs are the subject of major ongoing efforts to develop targeted cancer ...

The new study can help understanding diseases stemming from the abnormal functions of the human receptor tyrosine kinases, RTKs. Much of the cell-to-cell communication is facilitated in humans by 58 ...

In 2015, researchers at UC San Francisco found a structure inside of tumor cells that biologists had never seen before. Even more surprising, a closer examination of the structure revealed that it ...

BUFFALO, N.Y. -- During normal growth and development, cells in the body communicate with each other through protein receptors on the cell surface. Among the proteins used for this communication are ...

Researchers have mapped interactions among all human membrane RTKs and PTPs, providing clues how these proteins work in normal cells and how they can go wrong in cancer. In 2011, Igor Stagljar, a ...

Immuno-positron emission tomography (PET) imaging can provide early insight into a tumor's response to targeted therapy, allowing physicians to select the most effective treatment for patients who ...

Receptor Tyrosine Kinases select RTKs) regulate many critical processes such as cell growth, differentiation, and survival through the recruitment of intracellular signaling molecules. Dysregulated ...

The alternative text for this image may have been generated using AI. Targeting receptor tyrosine kinases (RTKs) has become an important therapeutic approach for a wide range of human cancers. However ...

University of Toronto scientists have uncovered more than 300 drug targets in cancer, attracting interest from the pharmaceutical industry looking to develop more precise treatments. Led by Professor ...